查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1781928

傳染病診斷市場，按產品與服務、按檢測類型、按樣本類型、按疾病類型、按技術、按最終用戶、按國家/地區 - 行業分析、市場規模、市場佔有率及預測（2024 年至 2032 年）

Infectious Disease Diagnostic Market, By Product & Service, By Type of Testing, By Sample Type, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年傳染病診斷市場規模價值 229.18 億美元，2024 年至 2032 年的複合年成長率為 8.2%。

傳染病診斷市場-市場動態

傳染病日益流行

全球傳染病發生率的上升是傳染病診斷市場發展的關鍵驅動力。人口密度上升、全球旅行和氣候變遷等因素導致病原體迅速傳播。此外，抗生素抗藥性菌株和新型傳染源的出現，也加劇了對精準快速診斷工具的需求。早期精準診斷能及時治療，減少疾病傳播，改善患者預後。因此，醫療保健系統正在加大對先進診斷技術的投入，推動傳染病檢測和管理領域的市場成長和創新。

傳染病診斷市場—關鍵洞察

根據我們的研究分析師，全球傳染病診斷市場預計在 2024 年至 2032 年期間的複合年成長率約為 8.2%。

2023 年按產品和服務細分，試劑、試劑盒和消耗品類別佔據了市場主導地位。

基於技術，聚合酶鍊式反應 (PCR) 部門在 2023 年創造了最多的收入。

按地區分類，2023年北美是收入最高的地區。

傳染病診斷市場-細分分析：

全球傳染病診斷市場分為七類：產品和服務、最終用戶、檢測類型、樣本類型、疾病類型、技術和地區。

傳染病診斷市場按產品和服務細分為三大類：試劑、試劑盒和耗材；儀器；以及軟體和服務。試劑、試劑盒和耗材包括進行診斷測試所需的基本化學品、檢測試劑盒和材料。儀器是指用於執行診斷程序的設備和機器，例如PCR儀、免疫分析儀和顯微鏡。軟體和服務包括資料管理工具、診斷軟體和支援服務，可提高測試準確性並簡化實驗室工作流程。在這些細分市場中，試劑、試劑盒和耗材佔據市場主導地位，因為它們在實驗室和醫院的常規檢測中有著反覆出現的需求。它們的高消費率和在測試準確性方面的關鍵作用使這一細分市場成為傳染病診斷市場的主要收入驅動力。

傳染病診斷市場按技術分為幾個關鍵領域：免疫診斷、臨床微生物學、聚合酶鍊式反應 (PCR)、恆溫核酸擴增技術、DNA 定序和下一代定序 (NGS)、DNA 微陣列和其他新興技術。免疫診斷涉及檢測抗原或抗體以識別感染。臨床微生物學專注於培養和鑑定微生物。 PCR 和恆溫核酸擴增是擴增病原體 DNA 或 RNA 以進行精確檢測的分子技術。 DNA 定序和 NGS 為病原體鑑定和抗藥性分析提供全面的遺傳訊息，而 DNA 微陣列則能夠進行大規模基因表現分析。其中，聚合酶鍊式反應 (PCR) 因其高靈敏度、特異性、快速的周轉時間以及在全球臨床實驗室的廣泛應用而佔據市場主導地位，使其成為準確傳染病檢測的首選。

傳染病診斷市場—地理洞察

從地理來看，傳染病診斷市場分佈於北美、亞太、拉丁美洲、歐洲、中東和非洲。這些地區根據業務來源國進一步分類。

北美是傳染病診斷市場的主導地區，其驅動力源自於其先進的醫療基礎設施、高昂的醫療支出以及尖端診斷技術的廣泛應用。美國尤其憑藉其在研發方面的大量投入、強大的監管支持以及大型診斷公司的存在，佔據了市場領先地位。該地區對早期疾病檢測的重視、傳染病患者的上升以及醫療服務提供者日益增強的醫療意識，進一步推動了市場的成長。此外，政府為提升診斷能力所採取的措施以及對快速即時檢測的需求日益成長，也進一步鞏固了北美在該市場的主導地位。

亞太地區是傳染病診斷的另一個重要市場，其快速成長得益於龐大且不斷成長的人口、日益普及的醫療保健服務以及日益加重的傳染病負擔。中國和印度等國家由於醫療基礎設施的擴張和政府醫療服務支出的增加，推動了需求的成長。該地區受益於人們日益成長的醫療意識、更完善的診斷設施以及日益壯大的中產階級對更優質醫療保健的追求。此外，結核病、登革熱和新冠肺炎 (COVID-19) 等傳染病的爆發凸顯了對強大診斷解決方案的需求，這使得亞太地區成為該領域一個快速成長且具有戰略重要性的市場。

傳染病診斷市場-競爭格局：

傳染病診斷市場由雅培、羅氏公司、賽默飛世爾科技和生物梅里埃等領導企業主導，這些企業憑藉豐富的產品組合和持續創新佔據主導地位。這些公司在研發方面投入大量資金，以提高診斷的準確性、速度和自動化程度，以滿足嚴格的監管標準。專注於分子診斷和即時檢測技術的新興公司也推動了競爭環境。隨著企業尋求擴大地域覆蓋範圍和技術能力，最終改善全球傳染病的檢測和病患治療效果，策略性收購與合作日益常見。

最新動態：

2025 年 3 月，雅培推出了一種新的呼吸道感染快速分子檢測，可在 30 分鐘內得出結果，增強了即時診斷能力。

2024 年 1 月，羅氏擴大了其診斷檢測產品組合，推出了高靈敏度的 COVID-19 和流感多重檢測，並提高了多種病原體的同時檢測能力。

目錄

第1章：傳染病診斷市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 傳染病診斷市場（按產品和服務）
    • 傳染病診斷市場依檢測類型分類
    • 傳染病診斷市場（按樣本類型）
    • 傳染病診斷市場（依疾病類型）
    • 傳染病診斷市場技術片段
    • 傳染病診斷市場（按最終用戶）片段
    • 傳染病診斷市場（按國家/地區）
    • 傳染病診斷市場（按地區）
  • 競爭洞察

第3章：傳染病診斷關鍵市場趨勢

  • 傳染病診斷市場促進因素
    • 市場促進因素的影響分析
  • 傳染病診斷市場的限制因素
    • 市場限制的影響分析
  • 傳染病診斷市場機遇
  • 傳染病診斷市場未來趨勢

第4章：傳染病診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：傳染病診斷市場：COVID-19影響分析

  • COVID-19 之前的影響分析
  • 新冠疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長細分市場
    • 最鬆散的細分市場
    • 邊際損失市場區隔

第6章：傳染病診斷市場格局

  • 2023年傳染病診斷市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：傳染病診斷市場－依產品及服務

  • 概述
    • 按產品和服務分類的細分市場佔有率分析
    • 試劑、試劑盒及耗材
    • 儀器
    • 軟體與服務

第8章：傳染病診斷市場－依檢測類型

  • 概述
    • 按測試類型進行細分佔有率分析
    • 實驗室測試
    • POC 測試

第9章：傳染病診斷市場－依樣本類型

  • 概述
    • 依樣本類型進行細分佔有率分析
    • 血液、血清和血漿
    • 尿
    • 其他樣本類型

第10章：傳染病診斷市場－依疾病類型

  • 概述
    • 按疾病類型分類的細分佔有率分析
    • 肝炎
      • B型肝炎
      • C型肝炎
      • 其他肝炎疾病
    • 愛滋病
    • 院內感染
    • 蚊媒疾病
    • HPV
    • 沙眼衣原體
    • 淋病奈瑟菌
    • 結核
    • 流感
    • 梅毒
    • 新冠肺炎
    • 其他傳染病

第 11 章：傳染病診斷市場 - 按技術

  • 概述
    • 按技術細分的市場佔有率分析
    • 免疫診斷
    • 臨床微生物學
    • 聚合酶鍊式反應
    • 等溫核酸擴增技術
    • DNA定序與次世代定序
    • DNA微陣列
    • 其他技術

第 12 章：傳染病診斷市場 - 按最終用戶

  • 概述
    • 按技術細分的市場佔有率分析
    • 診斷實驗室
    • 醫院和診所
    • 學術研究機構
    • 其他最終用戶

第13章：傳染病診斷市場－按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美傳染病診斷主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品和服務）
    • 北美市場規模及預測（依測試類型）
    • 北美市場規模和預測（按樣本類型）
    • 北美市場規模及預測（按疾病類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲傳染病診斷主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品和服務）
    • 歐洲市場規模及預測（依測試類型）
    • 歐洲市場規模及預測（依樣本類型）
    • 歐洲市場規模及預測（依疾病類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區傳染病診斷主要製造商
    • 亞太市場規模及預測（按國家/地區）
    • 亞太市場規模及預測（依產品及服務）
    • 亞太市場規模及預測（依測試類型）
    • 亞太市場規模及預測（依樣本類型）
    • 亞太市場規模及預測（依疾病類型）
    • 亞太市場規模及預測（按技術）
    • 亞太市場規模及預測（依最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲傳染病診斷主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品和服務）
    • 拉丁美洲市場規模及預測（按測試類型）
    • 拉丁美洲市場規模及預測（依樣本類型）
    • 拉丁美洲市場規模及預測（按疾病類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲傳染病診斷主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品和服務）
    • 中東和非洲市場規模及預測（按測試類型）
    • 中東和非洲市場規模及預測（按樣本類型）
    • 中東和非洲市場規模及預測（按疾病類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第14章：傳染病診斷產業主要供應商分析

  • 競爭儀錶板
  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Abbott
    • Biomerieux
    • Siemens Healthineers Ag
    • Danaher
    • Thermo Fisher Scientific Inc.
    • Hologic, Inc.
    • Becton, Dickinson And Company
    • Revvity
    • Qiagen
    • Seegene Inc.
    • Quidelortho Corporation
    • Grifols, SA
    • Diasorin SPA
    • Bio-Rad Laboratories, Inc.
    • Sysmex Corporation
    • Others

第 15 章：360 度分析師視角

第 16 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5370

REPORT HIGHLIGHT

Infectious Disease Diagnostic Market size was valued at USD 22,918 Million in 2024, expanding at a CAGR of 8.2% from 2024 to 2032.

Infectious Disease Diagnostic refers to the process and methods used to detect, identify, and confirm the presence of pathogens such as bacteria, viruses, fungi, or parasites that cause infectious diseases in humans or animals. This diagnostic process employs various techniques, including laboratory tests like culture, microscopy, molecular assays (e.g., PCR), antigen detection, and serology. Accurate and timely infectious disease diagnostics are crucial for appropriate treatment decisions, infection control, and epidemiological surveillance. These diagnostics help differentiate infectious agents, monitor disease progression, and guide public health interventions to prevent outbreaks and manage patient care effectively.

Infectious Disease Diagnostic Market- Market Dynamics

Growing Prevalence of Infectious Diseases

The increasing incidence of infectious diseases worldwide is a key driver for the infectious disease diagnostics market. Factors such as rising population density, global travel, and climate change contribute to the rapid spread of pathogens. Additionally, the emergence of antibiotic-resistant strains and novel infectious agents has intensified the need for accurate, rapid diagnostic tools. Early and precise diagnosis enables timely treatment, reducing disease transmission and improving patient outcomes. Consequently, healthcare systems are investing more in advanced diagnostic technologies, fueling market growth and innovation in infectious disease detection and management.

Infectious Disease Diagnostic Market- Key Insights

According to our research analyst, the global Infectious Disease Diagnostic Market is expected to develop at a CAGR of approximately 8.2% between 2024-2032.

Segmented by Product And Service in 2023, the Reagents, Kits, And Consumables category dominated the market.

Based on Technology, the Polymerase Chain Reaction (PCR) segment generated the most income in 2023.

On the basis of region, in 2023, North America was the region with the highest revenue.

Infectious Disease Diagnostic Market- Segmentation Analysis:

The global Infectious Disease Diagnostic Market is divided into Seven categories: Product & Service, End User, Type of Testing, Sample Type, Disease Type, Technology, and Region.

The infectious disease diagnostics market is segmented by product and service into three main categories: reagents, kits, and consumables; instruments; and software & services. Reagents, kits, and consumables include the essential chemicals, test kits, and materials required for conducting diagnostic tests. Instruments refer to the devices and machinery used to perform diagnostic procedures, such as PCR machines, immunoassay analyzers, and microscopes. Software & services encompass data management tools, diagnostic software, and support services that enhance test accuracy and streamline laboratory workflows. Among these segments, reagents, kits, and consumables dominate the market due to their recurring demand in laboratories and hospitals for routine testing. Their high consumption rate and critical role in test accuracy make this segment a primary revenue driver in the infectious disease diagnostics market.

The infectious disease diagnostics market is categorized by technology into several key segments: immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing (NGS), DNA microarray, and other emerging technologies. Immunodiagnostics involves detecting antigens or antibodies to identify infections. Clinical microbiology focuses on culturing and identifying microorganisms. PCR and isothermal nucleic acid amplification are molecular techniques amplifying pathogen DNA or RNA for precise detection. DNA sequencing and NGS provide comprehensive genetic information for pathogen identification and resistance profiling, while DNA microarrays enable large-scale gene expression analysis. Among these, polymerase chain reaction (PCR) dominates the market due to its high sensitivity, specificity, rapid turnaround time, and widespread adoption in clinical laboratories worldwide, making it the preferred choice for accurate infectious disease detection.

Infectious Disease Diagnostic Market- Geographical Insights

Geographically, the Infectious Disease Diagnostic Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the infectious disease diagnostics market, driven by advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of cutting-edge diagnostic technologies. The U.S., in particular, leads due to significant investments in research and development, strong regulatory support, and the presence of major diagnostic companies. The region's focus on early disease detection, rising prevalence of infectious diseases, and growing awareness among healthcare providers further fuel market growth. Additionally, government initiatives to improve diagnostic capabilities and the increasing demand for rapid point-of-care testing contribute to North America's commanding position in this market.

Asia Pacific is another key market for infectious disease diagnostics, experiencing rapid growth fueled by a large and growing population, increasing healthcare access, and rising infectious disease burden. Countries like China and India drive demand due to expanding healthcare infrastructure and increased government spending on healthcare services. The region benefits from rising awareness, improved diagnostic facilities, and a growing middle class seeking better healthcare. Additionally, the outbreak of infectious diseases such as tuberculosis, dengue, and COVID-19 has emphasized the need for robust diagnostic solutions, positioning Asia Pacific as a fast-growing and strategically important market in this sector.

Infectious Disease Diagnostic Market- Competitive Landscape:

The infectious disease diagnostic market is shaped by leading players such as Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and bioMerieux, which dominate through extensive product portfolios and continuous innovation. These companies invest heavily in research and development to enhance diagnostic accuracy, speed, and automation, meeting stringent regulatory standards. The competitive environment is also driven by emerging firms focusing on molecular diagnostics and point-of-care testing technologies. Strategic acquisitions and collaborations are common as companies seek to expand their geographic presence and technological capabilities, ultimately improving infectious disease detection and patient outcomes worldwide.

Recent Developments:

In March 2025, Abbott launched a new rapid molecular test for respiratory infections that delivers results in under 30 minutes, enhancing point-of-care diagnostics.

In January 2024, Roche expanded its diagnostic testing portfolio with the introduction of a highly sensitive COVID-19 and flu multiplex assay, improving simultaneous detection of multiple pathogens.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Biomerieux
  • Siemens Healthineers Ag
  • Danaher
  • Thermo Fisher Scientific Inc.
  • Hologic, Inc.
  • Becton, Dickinson And Company
  • Revvity
  • Qiagen
  • Seegene Inc.
  • Quidelortho Corporation
  • Grifols, S.A.
  • Diasorin S.P.A.
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Others

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2019 - 2032

  • Reagents, Kits, And Consumables
  • Instruments
  • Software & Services

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Research Institutes
  • Other End Users

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TYPE OF TESTING - MARKET ANALYSIS, 2019 - 2032

  • Laboratory Testing
  • POC Testing

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY DISEASE TYPE - MARKET ANALYSIS, 2019 - 2032

  • Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other Hepatitis Diseases
  • HIV
  • Hospital-Acquired Infections
  • Mosquito-Borne Diseases
  • HPV
  • Chlamydia Trachomatis
  • Neisseria Gonorrhea
  • Tuberculosis
  • Influenza
  • Syphilis
  • Covid-19
  • Other Infectious Diseases

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Dna Sequencing & Next-Generation Sequencing
  • Dna Microarray
  • Other Technologies

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY SAMPLE TYPE - MARKET ANALYSIS, 2019 - 2032

  • Blood, Serum, And Plasma
  • Urine
  • Other Sample Types

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Disease Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Disease Diagnostic Market Snippet by Product & Service
    • 2.1.2. Infectious Disease Diagnostic Market Snippet by Type of Testing
    • 2.1.3. Infectious Disease Diagnostic Market Snippet by Sample Type
    • 2.1.4. Infectious Disease Diagnostic Market Snippet by Disease Type
    • 2.1.5. Infectious Disease Diagnostic Market Snippet by Technology
    • 2.1.6. Infectious Disease Diagnostic Market Snippet by End User
    • 2.1.7. Infectious Disease Diagnostic Market Snippet by Country
    • 2.1.8. Infectious Disease Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Disease Diagnostic Key Market Trends

  • 3.1. Infectious Disease Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Disease Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Disease Diagnostic Market Opportunities
  • 3.4. Infectious Disease Diagnostic Market Future Trends

4. Infectious Disease Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Disease Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infectious Disease Diagnostic Market Landscape

  • 6.1. Infectious Disease Diagnostic Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Disease Diagnostic Market - By Product & Service

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product & Service, 2023 & 2032 (%)
    • 7.1.2. Reagents, Kits, And Consumables
    • 7.1.3. Instruments
    • 7.1.4. Software & Services

8. Infectious Disease Diagnostic Market - By Type of Testing

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type of Testing, 2023 & 2032 (%)
    • 8.1.2. Laboratory Testing
    • 8.1.3. POC Testing

9. Infectious Disease Diagnostic Market - By Sample Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
    • 9.1.2. Blood, Serum, And Plasma
    • 9.1.3. Urine
    • 9.1.4. Other Sample Types

10. Infectious Disease Diagnostic Market - By Disease Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 10.1.2. Hepatitis
      • 10.1.2.1. Hepatitis B
      • 10.1.2.2. Hepatitis C
      • 10.1.2.3. Other Hepatitis Diseases
    • 10.1.3. HIV
    • 10.1.4. Hospital-Acquired Infections
    • 10.1.5. Mosquito-Borne Diseases
    • 10.1.6. HPV
    • 10.1.7. Chlamydia Trachomatis
    • 10.1.8. Neisseria Gonorrhea
    • 10.1.9. Tuberculosis
    • 10.1.10. Influenza
    • 10.1.11. Syphilis
    • 10.1.12. Covid-19
    • 10.1.13. Other Infectious Diseases

11. Infectious Disease Diagnostic Market - By Technology

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 11.1.2. Immunodiagnostics
    • 11.1.3. Clinical Microbiology
    • 11.1.4. Polymerase Chain Reaction
    • 11.1.5. Isothermal Nucleic Acid Amplification Technology
    • 11.1.6. DNA Sequencing & Next-Generation Sequencing
    • 11.1.7. DNA Microarray
    • 11.1.8. Other Technologies

12. Infectious Disease Diagnostic Market - By End User

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 12.1.2. Diagnostic Laboratories
    • 12.1.3. Hospitals & Clinics
    • 12.1.4. Academic Research Institutes
    • 12.1.5. Other End Users

13. Infectious Disease Diagnostic Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. Infectious Disease Diagnostic Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.2.10. U.S.
      • 13.2.10.1. Overview
      • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.10.3. U.S. Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.2.10.4. U.S. Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.2.10.5. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.2.10.6. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.2.10.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.2.10.8. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.2.11. Canada
      • 13.2.11.1. Overview
      • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.11.3. Canada Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.2.11.4. Canada Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.2.11.5. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.2.11.6. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.2.11.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.2.11.8. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. Infectious Disease Diagnostic Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.10. Germany
      • 13.3.10.1. Overview
      • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.10.3. Germany Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.10.4. Germany Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.10.5. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.10.6. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.10.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.10.8. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.11. Italy
      • 13.3.11.1. Overview
      • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.11.3. Italy Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.11.4. Italy Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.11.5. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.11.6. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.11.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.11.8. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.12. United Kingdom
      • 13.3.12.1. Overview
      • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.12.3. United Kingdom Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.12.4. United Kingdom Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.12.5. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.12.6. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.12.7. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.12.8. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.13. France
      • 13.3.13.1. Overview
      • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.13.3. France Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.13.4. France Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.13.5. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.13.6. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.13.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.13.8. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.14. Russia
      • 13.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.14.2. Russia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.14.3. Russia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.14.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.14.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.14.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.15. Netherlands
      • 13.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.15.2. Netherlands Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.15.3. Netherlands Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.15.4. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.15.5. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.15.6. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.15.7. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.16. Sweden
      • 13.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.16.2. Sweden Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.16.3. Sweden Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.16.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.16.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.16.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.16.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.17. Poland
      • 13.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.17.2. Poland Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.17.3. Poland Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.17.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.18. Rest of Europe
      • 13.3.18.1. Overview
      • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.18.3. Rest of the Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.18.4. Rest of the Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.18.5. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.18.6. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.18.8. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. Infectious Disease Diagnostic Key Manufacturers in Asia Pacific
    • 13.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.4.4. Asia Pacific Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.4.5. Asia Pacific Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.4.6. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.4.7. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.4.8. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.4.9. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.10. India
      • 13.4.10.1. Overview
      • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.10.3. India Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.10.4. India Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.10.5. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.10.6. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.10.8. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.11. China
      • 13.4.11.1. Overview
      • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.11.3. China Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.11.4. China Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.11.5. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.11.6. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.11.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.11.8. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.12. Japan
      • 13.4.12.1. Overview
      • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.12.3. Japan Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.12.4. Japan Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.12.5. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.12.6. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.12.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.12.8. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.13. South Korea
      • 13.4.13.1. Overview
      • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.13.3. South Korea Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.13.4. South Korea Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.13.5. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.13.6. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.13.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.13.8. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.14. Australia
      • 13.4.14.1. Overview
      • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.14.3. Australia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.14.4. Australia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.14.5. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.14.6. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.14.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.14.8. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.15. Thailand
      • 13.4.15.1. Overview
      • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.15.3. Thailand Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.15.4. Thailand Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.15.5. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.15.6. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.15.8. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.16. Indonesia
      • 13.4.16.1. Overview
      • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.16.3. Indonesia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.16.4. Indonesia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.16.5. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.16.6. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.16.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.16.8. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.17. Philippines
      • 13.4.17.1. Overview
      • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.17.3. Philippines Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.17.4. Philippines Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.17.5. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.17.6. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.17.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.17.8. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.18. Rest of APAC
      • 13.4.18.1. Overview
      • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.18.3. Rest of APAC Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.18.4. Rest of APAC Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.18.5. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.18.6. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.18.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.18.8. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5. Latin America
    • 13.5.1. Overview
    • 13.5.2. Infectious Disease Diagnostic Key Manufacturers in Latin America
    • 13.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.5.4. Latin America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.5.5. Latin America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.5.6. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.5.7. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.5.8. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.5.9. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.10. Brazil
      • 13.5.10.1. Overview
      • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.10.3. Brazil Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.10.4. Brazil Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.10.5. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.10.6. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.10.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.10.8. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.11. Mexico
      • 13.5.11.1. Overview
      • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.11.3. Mexico Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.11.4. Mexico Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.11.5. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.11.6. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.11.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.11.8. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.12. Argentina
      • 13.5.12.1. Overview
      • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.12.3. Argentina Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.12.4. Argentina Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.12.5. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.12.6. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.12.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.12.8. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.13. Colombia
      • 13.5.13.1. Overview
      • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.13.3. Colombia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.13.4. Colombia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.13.5. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.13.6. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.13.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.13.8. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.14. Rest of LATAM
      • 13.5.14.1. Overview
      • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.14.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.14.8. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6. Middle East and Africa
    • 13.6.1. Overview
    • 13.6.2. Infectious Disease Diagnostic Key Manufacturers in Middle East and Africa
    • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.6.4. Middle East and Africa Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.6.5. Middle East and Africa Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.6.6. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.6.7. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.10. Saudi Arabia
      • 13.6.10.1. Overview
      • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.10.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.10.8. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.11. United Arab Emirates
      • 13.6.11.1. Overview
      • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.11.6. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.11.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.11.8. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.12. Israel
      • 13.6.12.1. Overview
      • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.12.3. Israel Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.12.4. Israel Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.12.5. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.12.6. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.12.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.12.8. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.13. Turkey
      • 13.6.13.1. Overview
      • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.13.3. Turkey Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.13.4. Turkey Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.13.5. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.13.6. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.13.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.13.8. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.14. Algeria
      • 13.6.14.1. Overview
      • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.14.3. Algeria Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.14.4. Algeria Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.14.5. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.14.6. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.14.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.14.8. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.15. Egypt
      • 13.6.15.1. Overview
      • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.15.3. Egypt Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.15.4. Egypt Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.15.5. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.15.6. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.15.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.15.8. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.16. Rest of MEA
      • 13.6.16.1. Overview
      • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.16.3. Rest of MEA Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.16.4. Rest of MEA Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.16.5. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.16.6. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.16.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.16.8. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- Infectious Disease Diagnostic Industry

  • 14.1. Competitive Dashboard
  • 14.2. Company Profiles
    • 14.2.1. F. Hoffmann-La Roche Ltd.
    • 14.2.2. Abbott
    • 14.2.3. Biomerieux
    • 14.2.4. Siemens Healthineers Ag
    • 14.2.5. Danaher
    • 14.2.6. Thermo Fisher Scientific Inc.
    • 14.2.7. Hologic, Inc.
    • 14.2.8. Becton, Dickinson And Company
    • 14.2.9. Revvity
    • 14.2.10. Qiagen
    • 14.2.11. Seegene Inc.
    • 14.2.12. Quidelortho Corporation
    • 14.2.13. Grifols, S.A.
    • 14.2.14. Diasorin S.P.A.
    • 14.2.15. Bio-Rad Laboratories, Inc.
    • 14.2.16. Sysmex Corporation
    • 14.2.17. Others

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us